Alhambra Investment Partners LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 3.1% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 25,015 shares of the biopharmaceutical company’s stock after purchasing an additional 751 shares during the period. Bristol-Myers Squibb makes up about […]
Baron Silver Stevens Financial Advisors LLC cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 9.1% in the 1st quarter, Holdings Channel.com reports. The fund owned 3,989 shares of the biopharmaceutical company’s stock after selling 398 shares during the period. Baron Silver Stevens Financial Advisors LLC’s holdings in Bristol-Myers Squibb were […]
Hennessy Advisors Inc. cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 1.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 81,400 shares of the biopharmaceutical company’s stock after selling 1,600 shares during the quarter. Hennessy Advisors […]
Webster Bank N. A. trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 3.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,823 shares of the biopharmaceutical company’s stock after selling 1,263 shares during the period. Webster Bank N. A.’s […]
Drive Wealth Management LLC boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Get Rating) by 10.8% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,313 shares of the biopharmaceutical company’s stock after buying an additional 811 shares during the period. Drive Wealth Management […]